Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for the Targeted Treatment of Bullous Pemphigoid (BP)
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Healio23d
Dupilumab does not desensitize children with peanut allergy
Following receipt of dupilumab for 24 weeks ... and those weighing at least 20 kg but less than 60 kg (n = 20) receiving a 200 mg dose plus a 400 mg loading dose. Researchers gave a double ...
Healio12d
Top in allergy/asthma: Dupilumab ineffective for peanut desensitization; asthma blood test
Fewer than 10% of children or adolescents with peanut allergy passed a desnsitiaztion food challenge after receiving dupilumab for 24 weeks. Image: Adobe Stock “The impact of the findings for ...